Works matching IS 02683369 AND DT 2013 AND VI 48 AND IP 2

Results: 37

Neoantigen and tumor antigen-specific immunity transferred from immunized donors is detectable early after allogeneic transplantation in myeloma patients.

Published in:

Bone Marrow Transplantation, 2013, v. 48, n. 2, p. 269, doi. 10.1038/bmt.2012.132

By:

Foglietta, M;
Neelapu, S S;
Kwak, L W;
Jiang, Y;
Nattamai, D;
Lee, S-T;
Fowler, D H;
Sportes, C;
Gress, R E;
Steinberg, S M;
Vence, L M;
Radvanyi, L;
Dwyer, K C;
Qazilbash, M H;
Bryant, R N K;
Bishop, M R

Publication type:

Article

Cord blood transplantation in aplastic anemia.

Published in:

Bone Marrow Transplantation, 2013, v. 48, n. 2, p. 201, doi. 10.1038/bmt.2012.252

By:

Peffault de Latour, R;
Rocha, V;
Socié, G

Publication type:

Article

Standard treatment of acquired SAA in adult patients 18-40 years old with an HLA-identical sibling donor.

Published in:

Bone Marrow Transplantation, 2013, v. 48, n. 2, p. 178, doi. 10.1038/bmt.2012.223

By:

Aljurf, M;
Al-Zahrani, H;
Van Lint, M T;
Passweg, J R

Publication type:

Article

Front-line immunosuppressive treatment of acquired aplastic anemia.

Published in:

Bone Marrow Transplantation, 2013, v. 48, n. 2, p. 174, doi. 10.1038/bmt.2012.222

By:

Dufour, C;
Svahn, J;
Bacigalupo, A

Publication type:

Article

A phase II study of sirolimus, tacrolimus and rabbit anti-thymocyte globulin as GVHD prophylaxis after unrelated-donor PBSC transplant.

Published in:

Bone Marrow Transplantation, 2013, v. 48, n. 2, p. 278, doi. 10.1038/bmt.2012.175

By:

Khaled, S K;
Palmer, J;
Stiller, T;
Senitzer, D;
Maegawa, R;
Rodriguez, R;
Parker, P M;
Nademanee, A;
Cai, J-L;
Snyder, D S;
Karanes, C;
Osorio, E;
Thomas, S H;
Forman, S J;
Nakamura, R

Publication type:

Article

Successful syngeneic PBSC transplantation for a patient with refractory Evans syndrome.

Published in:

Bone Marrow Transplantation, 2013, v. 48, n. 2, p. 312, doi. 10.1038/bmt.2012.136

By:

Mori, M;
Hiwatari, M;
Takita, J;
Ida, K;
Kawaguchi, H

Publication type:

Article

Haploidentical transplantation in patients with acquired aplastic anemia.

Published in:

Bone Marrow Transplantation, 2013, v. 48, n. 2, p. 183, doi. 10.1038/bmt.2012.231

By:

Ciceri, F;
Lupo-Stanghellini, M T;
Korthof, E T

Publication type:

Article

Intravenous ribavirin for respiratory syncytial viral infections in pediatric hematopoietic SCT recipients.

Published in:

Bone Marrow Transplantation, 2013, v. 48, n. 2, p. 265, doi. 10.1038/bmt.2012.134

By:

Molinos-Quintana, A;
Pérez-de Soto, C;
Gómez-Rosa, M;
Pérez-Simón, J A;
Pérez-Hurtado, J M

Publication type:

Article

Diagnosis of acquired aplastic anemia.

Published in:

Bone Marrow Transplantation, 2013, v. 48, n. 2, p. 162, doi. 10.1038/bmt.2012.230

By:

Rovó, A;
Tichelli, A;
Dufour, C

Publication type:

Article

Treatment of aplastic anaemia in elderly patients aged >60 years.

Published in:

Bone Marrow Transplantation, 2013, v. 48, n. 2, p. 180, doi. 10.1038/bmt.2012.224

By:

Tichelli, A;
Marsh, J C W

Publication type:

Article

G-CSF plus plerixafor (Mozobil) to mobilize hematopoietic stem cells in patients with thrombocytopenia or leukopenia prior to auto-SCT.

Published in:

Bone Marrow Transplantation, 2013, v. 48, n. 2, p. 303, doi. 10.1038/bmt.2012.125

By:

Micallef, I N;
Jacobsen, E D;
Shaughnessy, P;
Gandhi, P J;
Calandra, G;
van Rhee, F;
Uberti, J

Publication type:

Article

Treatment and hematopoietic SCT in aplastic anemia.

Published in:

Bone Marrow Transplantation, 2013, v. 48, n. 2, p. 161, doi. 10.1038/bmt.2012.229

By:

Passweg, J R;
Aljurf, M

Publication type:

Article

Supportive care in severe and very severe aplastic anemia.

Published in:

Bone Marrow Transplantation, 2013, v. 48, n. 2, p. 168, doi. 10.1038/bmt.2012.220

By:

Höchsmann, B;
Moicean, A;
Risitano, A;
Ljungman, P;
Schrezenmeier, H

Publication type:

Article

Management of acquired aplastic anemia in children.

Published in:

Bone Marrow Transplantation, 2013, v. 48, n. 2, p. 191, doi. 10.1038/bmt.2012.235

By:

Korthof, E T;
Békássy, A N;
Hussein, A A

Publication type:

Article

Foscarnet against human herpesvirus (HHV)-6 reactivation after allo-SCT: breakthrough HHV-6 encephalitis following antiviral prophylaxis.

Published in:

Bone Marrow Transplantation, 2013, v. 48, n. 2, p. 257, doi. 10.1038/bmt.2012.121

By:

Ogata, M;
Satou, T;
Inoue, Y;
Takano, K;
Ikebe, T;
Ando, T;
Ikewaki, J;
Kohno, K;
Nishida, A;
Saburi, M;
Miyazaki, Y;
Ohtsuka, E;
Saburi, Y;
Fukuda, T;
Kadota, J

Publication type:

Article

Are there still reasons to believe that high-dose chemotherapy has a role in breast cancer management?

Published in:

Bone Marrow Transplantation, 2013, v. 48, n. 2, p. 305, doi. 10.1038/bmt.2012.126

By:

Castagna, L;
Martino, M

Publication type:

Article

Alternative immunosuppression in patients failing immunosuppression with ATG who are not transplant candidates: Campath (Alemtuzumab).

Published in:

Bone Marrow Transplantation, 2013, v. 48, n. 2, p. 186, doi. 10.1038/bmt.2012.245

By:

Risitano, A M;
Schrezenmeier, H

Publication type:

Article

Early-phase GVHD gene expression profile in target versus non-target tissues: kidney, a possible target?

Published in:

Bone Marrow Transplantation, 2013, v. 48, n. 2, p. 284, doi. 10.1038/bmt.2012.120

By:

Sadeghi, B;
Al-Chaqmaqchi, H;
Al-Hashmi, S;
Brodin, D;
Hassan, Z;
Abedi-Valugerdi, M;
Moshfegh, A;
Hassan, M

Publication type:

Article

Autologous cord blood transplantation in a child with stage 4 neuroblastoma.

Published in:

Bone Marrow Transplantation, 2013, v. 48, n. 2, p. 317, doi. 10.1038/bmt.2012.146

By:

Wu, K-H;
Wang, S-M;
Wu, H-P;
Weng, T;
Peng, C-T;
Chao, Y-H

Publication type:

Article

Chronic GVHD: Where are we? Where do we want to be? Will immunomodulatory drugs help?

Published in:

Bone Marrow Transplantation, 2013, v. 48, n. 2, p. 203, doi. 10.1038/bmt.2012.76

By:

Linhares, Y P L;
Pavletic, S;
Gale, R P

Publication type:

Article

Incidence and risk factors of EBV reactivation after unrelated cord blood transplantation: a Eurocord and Société Française de Greffe de Moelle-Therapie Cellulaire collaborative study.

Published in:

Bone Marrow Transplantation, 2013, v. 48, n. 2, p. 253, doi. 10.1038/bmt.2012.117

By:

Dumas, P-Y;
Ruggeri, A;
Robin, M;
Crotta, A;
Abraham, J;
Forcade, E;
Bay, J-O;
Michallet, M;
Bertrand, Y;
Socié, G;
Ionescu, I;
Gluckman, E;
Milpied, N;
Rocha, V

Publication type:

Article

Omission of day-11 MTX, in combination with tacrolimus, is not associated with increased risk of acute graft-versus-host disease after allo-BMT.

Published in:

Bone Marrow Transplantation, 2013, v. 48, n. 2, p. 307, doi. 10.1038/bmt.2012.128

By:

Honda, A;
Kakihana, K;
Aoki, J;
Kobayashi, T;
Doki, N;
Sakamaki, H;
Ohashi, K

Publication type:

Article

The impact of center experience on results of reduced intensity: allogeneic hematopoietic SCT for AML. An analysis from the Acute Leukemia Working Party of the EBMT.

Published in:

Bone Marrow Transplantation, 2013, v. 48, n. 2, p. 238, doi. 10.1038/bmt.2012.131

By:

Giebel, S;
Labopin, M;
Mohty, M;
Mufti, G J;
Niederwieser, D;
Cornelissen, J J;
Janssen, J J W M;
Milpied, N;
Vindelov, L;
Petersen, E;
Arnold, R;
Bacigalupo, A;
Blaise, D;
Craddock, C;
Nagler, A;
Frassoni, F;
Sadus-Wojciechowska, M;
Rocha, V

Publication type:

Article

Cryopreservation of allogeneic PBSC from related and unrelated donors is associated with delayed platelet engraftment but has no impact on survival.

Published in:

Bone Marrow Transplantation, 2013, v. 48, n. 2, p. 243, doi. 10.1038/bmt.2012.118

By:

Medd, P;
Nagra, S;
Hollyman, D;
Craddock, C;
Malladi, R

Publication type:

Article

Alternative donor SCT for the treatment of MHC Class II deficiency.

Published in:

Bone Marrow Transplantation, 2013, v. 48, n. 2, p. 226, doi. 10.1038/bmt.2012.140

By:

Small, T N;
Qasim, W;
Friedrich, W;
Chiesa, R;
Bleesing, J J;
Scurlock, A;
Veys, P;
Sparber-Sauer, M

Publication type:

Article

Costs of autologous and allogeneic hematopoietic cell transplantation in the United States: a study using a large National Private Claims Database.

Published in:

Bone Marrow Transplantation, 2013, v. 48, n. 2, p. 294, doi. 10.1038/bmt.2012.133

By:

Majhail, N S;
Mau, L W;
Denzen, E M;
Arneson, T J

Publication type:

Article

Beating the odds: factors implicated in the speed and availability of unrelated haematopoietic cell donor provision.

Published in:

Bone Marrow Transplantation, 2013, v. 48, n. 2, p. 210, doi. 10.1038/bmt.2012.54

By:

Lown, R N;
Shaw, B E

Publication type:

Article

Donor selection for patients undergoing allogeneic hematopoietic SCT: assessment of the priorities of Canadian hematopoietic SCT physicians.

Published in:

Bone Marrow Transplantation, 2013, v. 48, n. 2, p. 314, doi. 10.1038/bmt.2012.137

By:

Tay, J;
Allan, D;
Tinmouth, A;
Coyle, D;
Hébert, P

Publication type:

Article

Management of adult patients older than 40 years refractory to at least one immunosuppressive course: HLA-identical sibling HSCT using fludarabine-based conditioning.

Published in:

Bone Marrow Transplantation, 2013, v. 48, n. 2, p. 196, doi. 10.1038/bmt.2012.251

By:

Maury, S;
Aljurf, M

Publication type:

Article

Unrelated donor search and unrelated donor transplantation in the adult aplastic anaemia patient aged 18-40 years without an HLA-identical sibling and failing immunosuppression.

Published in:

Bone Marrow Transplantation, 2013, v. 48, n. 2, p. 198, doi. 10.1038/bmt.2012.233

By:

Bacigalupo, A;
Marsh, J C W

Publication type:

Article

Tandem autologous-allo-SCT is feasible in patients with high-risk relapsed non-Hodgkin's lymphoma.

Published in:

Bone Marrow Transplantation, 2013, v. 48, n. 2, p. 249, doi. 10.1038/bmt.2012.116

By:

Crocchiolo, R;
Castagna, L;
Fürst, S;
El-Cheikh, J;
Faucher, C;
Oudin, C;
Granata, A;
Bouabdallah, R;
Coso, D;
Chabannon, C;
Balzarotti, M;
Santoro, A;
Blaise, D

Publication type:

Article

Stem cell mobilization in heavily pretreated multiple myeloma patients with prior high dose melphalan and auto-SCT.

Published in:

Bone Marrow Transplantation, 2013, v. 48, n. 2, p. 310, doi. 10.1038/bmt.2012.135

By:

Khaled, Y;
Al-Hazzouri, A;
Mizrachi, A;
Reynolds, R;
Reddy, V;
Solh, M

Publication type:

Article

PBSC mobilization in newly diagnosed patients with POEMS syndrome: outcomes and prognostic factors.

Published in:

Bone Marrow Transplantation, 2013, v. 48, n. 2, p. 233, doi. 10.1038/bmt.2012.138

By:

Li, J;
Zhang, W;
Duan, M-H;
Jiao, L;
Zhu, T-N;
Han, B;
Zhang, L;
Gan, J;
Zhou, D-B

Publication type:

Article

Suicide after hematopoietic SCT: the story of AG.

Published in:

Bone Marrow Transplantation, 2013, v. 48, n. 2, p. 301, doi. 10.1038/bmt.2012.122

By:

Rozovski, U;
Arad, R;
Ben-Tal, O;
Shahar, T;
Naparstek, E

Publication type:

Article

Improved outcomes with novel agents and auto-SCT for multiple myeloma in African-American patients.

Published in:

Bone Marrow Transplantation, 2013, v. 48, n. 2, p. 319, doi. 10.1038/bmt.2012.148

By:

Saraf, S L;
Patel, P;
Ozer, H;
Peace, D J;
Quigley, J G;
Mahmud, N;
Rondelli, D

Publication type:

Article

Response to: 'Are there still reasons to believe that high-dose chemotherapy plays a role in breast cancer management?'.

Published in:

Bone Marrow Transplantation, 2013, v. 48, n. 2, p. 306, doi. 10.1038/bmt.2012.127

By:

Demirer, T

Publication type:

Article

Allogeneic hematopoietic stem cell donation-standardized assessment of donor outcome data: A consensus statement from the Worldwide Network for Blood and Marrow Transplantation (WBMT).

Published in:

Bone Marrow Transplantation, 2013, v. 48, n. 2, p. 220, doi. 10.1038/bmt.2012.119

By:

Halter, J P;
van Walraven, S M;
Worel, N;
Bengtsson, M;
Hägglund, H;
Nicoloso de Faveri, G;
Shaw, B E;
Schmidt, A H;
Fechter, M;
Madrigal, A;
Szer, J;
Aljurf, M D;
Weisdorf, D;
Horowitz, M M;
Greinix, H;
Niederwieser, D;
Gratwohl, A;
Kodera, Y;
Confer, D

Publication type:

Article